FDA Advisers Recommend Pulling Drug to Prevent Preterm Births From Market

Experts vote for withdrawal of Makena after studies find the drug didn’t provide a benefit while coming with potential side effects

The Food and Drug Administration, in Silver Spring, Md., is expected to order the drug Makena removed from the market.Health experts advising the Food and Drug Administration recommended the agencyThe advisers voted against the FDA allowing Covis Pharma Group’s Makena to remain on the market, after the drug

So why is mrna injections pulled after the data was forcefully pulled from Pfizer instead of waiting 75 years?Bet there won't be an answer.

España Últimas Noticias, España Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

FDA Says Makena Doesn't Prevent Premature Births, Seeks to Pull Drug From MarketThe maker of the only U.S. drug intended to prevent premature births is making a last-ditch effort to keep its medication on the market as health regulators revisit mounting evidence that it doesn't work
Fuente: NBCLA - 🏆 319. / 59 Leer más »

FDA pushes to remove pregnancy drug, company pushes backThe maker of a drug intended to reduce premature births is making a last-ditch effort to keep its medication on the market, even as health regulators insist that it doesn’t work.
Fuente: WTVYNews4 - 🏆 590. / 51 Leer más »

FDA pushes to remove pregnancy drug, company pushes backThe maker of a drug intended to reduce premature births is making a last-ditch effort to keep its medication on the market, even as health regulators insist that it doesn’t work. fda pregnancy kprc2 click2houston
Fuente: KPRC2 - 🏆 80. / 68 Leer más »

FDA pushes to remove pregnancy drug, company pushes backThe maker of the only U.S. drug intended to prevent premature births is making a last-ditch effort this week to keep its medication on the market, even as health regulators insist that it doesn't work.
Fuente: wjxt4 - 🏆 246. / 63 Leer más »